AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2014
Sep 13, 2014
30786_dirs_2014-09-12_aa03c4dc-3128-4791-891c-ac6a841c15da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2014-09-10
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-11 | Bio-Rad B Common Stock | M | 2600 | — | Acquired | 151078 | Direct |
| 2014-09-11 | Bio-Rad B Common Stock | F | 1113 | $119.69 | Disposed | 149965 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-10 | Restricted Stock Units | $0 | A | 10000 | Acquired | Bio-Rad B Common Stock (10000) | Direct | |
| 2014-09-10 | Non-Qualified Stock Option (right to buy) | $119.80 | A | 35000 | Acquired | 2024-09-10 | Bio-Rad B Common Stock (35000) | Direct |
| 2014-09-11 | Restricted Stock Units | $0 | M | 2600 | Disposed | Bio-Rad B Common Stock (2600) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 411252 | Direct |
| Bio-Rad B Common Stock | 12371 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
| Bio-Rad B Common Stock | 13726 | Indirect |
Footnotes
F1: Shares of Class B common stock acquired on the vesting of restricted stock units.
F2: The reporting person disclaims beneficial ownership of these shares.
F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4: The shares are held by a limited partnership of which the reporting person is a limited partner.
F5: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.
F6: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
F7: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.
F8: The restricted stock units vest in five equal annual installments beginning September 11, 2014.